Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN63081234) titled 'Ganrucao ointment for stage III pressure injuries' on Oct. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Active
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Condition:
Improved short-term healing outcomes in patients with stage III pressure injuries
Skin and Connective Tissue Diseases
Intervention:
This prospective, randomized, parallel-group study enrolled 60 patients with stage III pressure injuries between November 2016 and Octob...